357 related articles for article (PubMed ID: 32552404)
1. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
[TBL] [Abstract][Full Text] [Related]
2. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
[TBL] [Abstract][Full Text] [Related]
3. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
Gao S; Nelson J; Weinsheimer S; Winkler EA; Rutledge C; Abla AA; Gupta N; Shieh JT; Cooke DL; Hetts SW; Tihan T; Hess CP; Ko N; Walcott BP; McCulloch CE; Lawton MT; Su H; Pawlikowska L; Kim H
J Neurosurg; 2022 Jan; 136(1):148-155. PubMed ID: 34214981
[TBL] [Abstract][Full Text] [Related]
4. Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice.
Park ES; Kim S; Huang S; Yoo JY; Körbelin J; Lee TJ; Kaur B; Dash PK; Chen PR; Kim E
Ann Neurol; 2021 May; 89(5):926-941. PubMed ID: 33675084
[TBL] [Abstract][Full Text] [Related]
5. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
[TBL] [Abstract][Full Text] [Related]
6. KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway.
Xu H; Huo R; Li H; Jiao Y; Weng J; Wang J; Yan Z; Zhang J; Zhao S; He Q; Sun Y; Wang S; Cao Y
Stroke Vasc Neurol; 2023 Jun; 8(3):197-206. PubMed ID: 36418055
[TBL] [Abstract][Full Text] [Related]
7. Review of treatment and therapeutic targets in brain arteriovenous malformation.
Pan P; Weinsheimer S; Cooke D; Winkler E; Abla A; Kim H; Su H
J Cereb Blood Flow Metab; 2021 Dec; 41(12):3141-3156. PubMed ID: 34162280
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in intracranial arteriovenous malformations.
Goss JA; Huang AY; Smith E; Konczyk DJ; Smits PJ; Sudduth CL; Stapleton C; Patel A; Alexandrescu S; Warman ML; Greene AK
PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
[TBL] [Abstract][Full Text] [Related]
9. Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model.
Nguyen HL; Boon LM; Vikkula M
Hum Mol Genet; 2023 Jan; 32(2):276-289. PubMed ID: 35972810
[TBL] [Abstract][Full Text] [Related]
10. KRAS Activating Signaling Triggers Arteriovenous Malformations.
Cheng F; Nussinov R
Trends Biochem Sci; 2018 Jul; 43(7):481-483. PubMed ID: 29748115
[TBL] [Abstract][Full Text] [Related]
11. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
12. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-3131 derived from endothelial cells with KRAS mutation promotes EndMT by targeting PICK1 in brain arteriovenous malformations.
He Q; Huo R; Wang J; Xu H; Zhao S; Zhang J; Sun Y; Jiao Y; Weng J; Zhao J; Cao Y
CNS Neurosci Ther; 2023 May; 29(5):1312-1324. PubMed ID: 36718590
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications.
Ota T; Komiyama M
Interv Neuroradiol; 2020 Jun; 26(3):244-253. PubMed ID: 32024399
[TBL] [Abstract][Full Text] [Related]
15. H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors.
Serban D; Leng J; Cheresh D
Circ Res; 2008 Jun; 102(11):1350-8. PubMed ID: 18467631
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Basic Research for Brain Arteriovenous Malformation.
Barbosa Do Prado L; Han C; Oh SP; Su H
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731545
[TBL] [Abstract][Full Text] [Related]
18. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
19. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks.
Soon K; Li M; Wu R; Zhou A; Khosraviani N; Turner WD; Wythe JD; Fish JE; Nunes SS
Biomaterials; 2022 Sep; 288():121729. PubMed ID: 35999080
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
